TipRanks
MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235)
:2235
Hong Kong Market
2235
MicroTech Medical (Hangzhou) Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2235 full AI Analyst Report?

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Ratios

0 Followers

MicroTech Medical (Hangzhou) Co., Ltd. Class H Ratios

HK:2235's free cash flow for Q2 2026 was ¥0.58. For the 2026 fiscal year, HK:2235's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.19 6.39 11.41 21.67 26.61
Quick Ratio
 5.84 6.11 11.11 21.22 25.79
Cash Ratio
 5.24 5.32 10.17 20.19 25.02
Solvency Ratio
 0.32 0.18 -0.31 -1.17 -0.30
Operating Cash Flow Ratio
 0.29 0.11 -0.72 -1.64 -1.32
Short-Term Operating Cash Flow Coverage
 0.77 0.35 -29.88 -34.63 0.00
Net Current Asset Value
¥ 1.52B¥ 1.52B¥ 1.73B¥ 1.93B¥ 2.09B
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.04 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.05 0.05 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.05 0.04 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.15 1.09 1.05 1.04
Debt Service Coverage Ratio
 0.95 0.32 -25.75 -38.95 -749.63
Interest Coverage Ratio
 103.03 98.58 -92.33 -384.02 -219.01
Debt to Market Cap
 0.04 0.03 <0.01 <0.01 0.00
Interest Debt Per Share
 0.26 0.23 0.01 0.01 <0.01
Net Debt to EBITDA
 -13.42 -48.80 13.95 10.21 18.57
Profitability Margins
Gross Profit Margin
56.62%54.09%52.91%49.62%45.90%
EBIT Margin
11.41%2.70%-38.12%-78.64%-69.34%
EBITDA Margin
12.82%4.39%-35.12%-74.14%-63.50%
Operating Profit Margin
10.88%6.65%-18.07%-48.43%-18.55%
Pretax Profit Margin
10.02%6.11%-18.27%-50.27%-20.19%
Net Profit Margin
9.98%6.08%-18.26%-50.34%-20.19%
Continuous Operations Profit Margin
9.98%6.08%-18.26%-50.34%-20.19%
Net Income Per EBT
99.61%99.38%99.95%100.13%100.00%
EBT Per EBIT
92.05%91.88%101.10%103.81%108.85%
Return on Assets (ROA)
3.54%1.74%-2.94%-5.79%-1.53%
Return on Equity (ROE)
4.08%1.99%-3.20%-6.07%-1.58%
Return on Capital Employed (ROCE)
4.41%2.17%-3.16%-5.82%-1.46%
Return on Invested Capital (ROIC)
4.17%2.06%-3.15%-5.81%-1.45%
Return on Tangible Assets
3.58%1.76%-2.98%-5.88%-1.54%
Earnings Yield
3.29%1.40%-2.62%-5.36%-0.96%
Efficiency Ratios
Receivables Turnover
 5.79 4.41 2.91 3.38 3.51
Payables Turnover
 4.16 3.49 2.17 3.90 4.11
Inventory Turnover
 3.50 3.84 3.20 2.97 1.39
Fixed Asset Turnover
 3.49 2.99 1.69 2.45 1.66
Asset Turnover
 0.35 0.29 0.16 0.12 0.08
Working Capital Turnover Ratio
 0.54 0.40 0.19 0.12 0.08
Cash Conversion Cycle
 79.54 73.47 70.95 137.47 277.08
Days of Sales Outstanding
 63.09 82.77 125.43 108.13 104.08
Days of Inventory Outstanding
 104.25 95.17 113.94 122.85 261.78
Days of Payables Outstanding
 87.80 104.46 168.41 93.51 88.77
Operating Cycle
 167.34 177.94 239.36 230.98 365.86
Cash Flow Ratios
Operating Cash Flow Per Share
 0.20 0.08 -0.29 -0.36 -0.25
Free Cash Flow Per Share
 0.07 -0.02 -0.48 -0.43 -0.32
CapEx Per Share
 0.13 0.09 0.20 0.07 0.07
Free Cash Flow to Operating Cash Flow
 0.35 -0.19 1.69 1.19 1.28
Dividend Paid and CapEx Coverage Ratio
 1.54 0.84 -1.44 -5.33 -3.62
Capital Expenditure Coverage Ratio
 1.54 0.84 -1.45 -5.33 -3.62
Operating Cash Flow Coverage Ratio
 0.77 0.35 -28.70 -30.23 -150.17
Operating Cash Flow to Sales Ratio
 0.10 0.05 -0.35 -0.62 -0.62
Free Cash Flow Yield
1.22%-0.21%-8.46%-7.79%-3.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 29.09 71.23 -38.19 -18.67 -104.59
Price-to-Sales (P/S) Ratio
 2.98 4.33 6.98 9.40 21.12
Price-to-Book (P/B) Ratio
 1.23 1.42 1.22 1.13 1.66
Price-to-Free Cash Flow (P/FCF) Ratio
 82.25 -468.34 -11.82 -12.84 -26.67
Price-to-Operating Cash Flow Ratio
 29.46 89.93 -19.98 -15.25 -34.04
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.43 0.79 -0.07 2.72
Enterprise Value Multiple
 9.78 49.76 -5.91 -2.46 -14.70
Enterprise Value
 1.04B 1.44B 717.68M 453.60M 1.62B
EV to EBITDA
 9.79 49.76 -5.91 -2.46 -14.70
EV to Sales
 1.26 2.19 2.08 1.83 9.33
EV to Free Cash Flow
 34.72 -236.45 -3.52 -2.50 -11.78
EV to Operating Cash Flow
 12.21 45.40 -5.95 -2.96 -15.04
Tangible Book Value Per Share
 4.79 4.97 4.62 4.76 5.17
Shareholders’ Equity Per Share
 4.84 5.02 4.69 4.84 5.20
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 1.97 1.65 0.82 0.58 0.41
Net Income Per Share
 0.20 0.10 -0.15 -0.29 -0.08
Tax Burden
 1.00 0.99 1.00 1.00 1.00
Interest Burden
 0.88 2.27 0.48 0.64 0.29
Research & Development to Revenue
 0.10 0.12 0.22 0.28 0.18
SG&A to Revenue
 0.44 0.26 0.44 0.06 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.04 0.81 1.91 1.22 3.07
Currency in CNY